(Q37194977)

18 August 2017

1 reference

title

Understanding and harnessing the graft-versus-leukaemia effect (English)

1 reference

18 August 2017

1 reference

A John Barrett

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

28 June 2008

1 reference

British Journal of Haematology

18 August 2017

published in

1 reference

18 August 2017

volume

142

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

877-888

1 reference

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07260.X

10.1111/J.1365-2141.2008.07260.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference